Mycenax Biotech Inc. (TPEX:4726)
Taiwan
· Delayed Price · Currency is TWD 29.10
+0.35 (1.22%)
Apr 28, 2026, 1:30 PM CST
Mycenax Biotech Market Cap
Mycenax Biotech has a market cap or net worth of 6.03 billion as of April 28, 2026. Its market cap has decreased by -24.24% in one year.
Market Cap
6.03B
Enterprise Value
6.88B
Revenue
740.24M
Ranking
n/a
PE Ratio
n/a
Stock Price
29.10
Market Cap Chart
Since October 31, 2008, Mycenax Biotech's market cap has increased from 584.10M to 6.03B, an increase of 932.43%. That is a compound annual growth rate of 14.27%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sinphar Pharmaceutical | 6.02B |
| Savior Lifetec | 6.01B |
| AnnJi Pharmaceutical | 5.94B |
| Panion & Bf Biotech | 5.43B |
| Steminent Biotherapeutics | 5.20B |
| TaiGen Biopharmaceuticals Holdings | 7.19B |
| UnicoCell Biomed | 5.14B |
| Acepodia | 7.25B |